Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    19641206 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy
Conditions: Moderate to Severe Psoriasis.;   Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.
Intervention: Drug: Adalimumab, etanercept, infliximab
2 Completed Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
Condition: Psoriasis
Intervention: Drug: Sitagliptin (Januvia)
3 Completed Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
4 Completed Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
Condition: Plaque Psoriasis
Interventions: Drug: SOR007 Ointment 2.0%;   Drug: SOR007 Ointment 1.0%;   Drug: SOR007 Ointment 0.3%;   Drug: SOR007 Ointment 0.15%;   Drug: SOR007 Ointment Placebo;   Drug: Taclonex® Ointment
5 Unknown  An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
Conditions: Psoriasis Chronic;   Liver Fibrosis;   Fatty Liver;   Non-alcoholic Fatty Liver Disease
Intervention: Device: Transient elastography

Study has passed its completion date and status has not been verified in more than two years.